Valuation (41%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.71 | 52.97 |
PEG Ratio (TTM) | -1.97 | 7.36 |
P/S Ratio (TTM) | 1.34 | 7.07 |
P/B Ratio (TTM) | 3.80 | 10.14 |
P/FCF Ratio (TTM) | 12.72 | 85.07 |
Price to 5YR AVG Earnings Ratio | -84.32 | 58.39 |
Price to 5YR AVG FCF Ratio | 22.31 | 114.93 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.78% | 3.42% |
ROE (TTM) | -66.44% | 27.11% |
Net Profit Margin (TTM) | -23.38% | 17.36% |
ROIC 5YR AVG | 4.38% | 6.91% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -339.58% | 14.08% | -23.69% |
Revenue | 1.79% | -0.42% | 4.51% |
Net Income | -350.67% | 15.68% | -5.71% |
Cash Flow | 177.85% | -15.99% | 21.85% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.58 | 2.84 |
Quick Ratio (TTM) | 0.47 | 2.82 |
D/E Ratio (TTM) | 4.63 | 63.79 |
Interest Coverage (TTM) | 1.59 | 2.97 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 1.43 |
LTL to 5YR AVG FCF | 24.34 | 31.27 |
Shares Outstanding Growth 5YR AVG | 3.50% | 1.49% |